Portfolio company
Micrographia Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biodock
This company provides a cloud-based artificial intelligence platform for microscopy image analysis, serving pharmaceutical companies and academic research institutions.
Enable Medicine
Enable Medicine provides a cloud-based spatial biology platform for life science researchers and pharmaceutical companies to analyse cellular data and discover new drug targets.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
ViewsML
This company develops an artificial intelligence platform providing virtual biomarker staining of pathology images for biopharmaceutical researchers, clinical trial teams and diagnostic laboratories.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
CardiaTec Biosciences
This company develops an artificial intelligence platform to identify cardiovascular drug targets for pharmaceutical providers using large-scale multi-omics data.
